October 2017 tender notification
PHARMAC has resolved not to award any tenders for Sole Subsidised Supply Status or Hospital Supply Status this month.
* As part of a released publication of the September Tender Notification on September 29th, 2017, an item was incorrectly identified as awarded; salbutamol – oral liq 400 mcg per ml. This item was notified as an award for Sole Subsidised Supply Status in Section B and Hospital Supply Status in Section H of the Pharmaceutical Schedule in relation to the 2015/16 Invitation to tender.
Please note, PHARMAC has resolved not to award a tender for salbutamol – oral liq 400 mcg per ml and this product has been included in the below October 2017 tender notification as a tender decline.
Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status
PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in:
- the 2015/16 Invitation to Tender, dated 6 November 2015, and
- the 2016/17 Invitation to Tender, dated 3 November 2016.
2015/16 Invitation to Tender
|
Chemical name |
Line item |
|---|---|
|
Salbutamol |
Oral liq 400 mcg per ml |
2016/17 Invitation to Tender
|
Chemical name |
Line item |
|---|---|
|
Methylphenidate |
Tab immediate-release 5 mg |
|
Methylphenidate |
Tab immediate-release 10 mg |
|
Methylphenidate |
Tab immediate-release 20 mg |
|
Methylphenidate |
Tab sustained-release 20 mg |
|
Nitrofurantoin |
Tab 50 mg |
|
Nitrofurantoin |
Tab 100 mg |
For products included in the 2015/16 and 2016/17 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.